Pharmacological prophylaxis of venous thromboembolism during acute phase of spontaneous intracerebral hemorrhage: what do we know about risks and benefits?
about
Steps to consider in the approach and management of critically ill patient with spontaneous intracerebral hemorrhageProphylactic heparin in acute intracerebral hemorrhage: a propensity score-matched analysis of the INTERACT2 study.What's new in emergencies, trauma, and shock? Heparin in severe traumatic brain injury: Beyond venous thromboembolism prevention?Current Practice Trends for Use of Early Venous Thromboembolism Prophylaxis After Intracerebral Hemorrhage.European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
P2860
Pharmacological prophylaxis of venous thromboembolism during acute phase of spontaneous intracerebral hemorrhage: what do we know about risks and benefits?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacological prophylaxis of ...... know about risks and benefits?
@en
type
label
Pharmacological prophylaxis of ...... know about risks and benefits?
@en
prefLabel
Pharmacological prophylaxis of ...... know about risks and benefits?
@en
P2093
P2860
P356
P1476
Pharmacological prophylaxis of ...... know about risks and benefits?
@en
P2093
Alejandro A Rabinstein
Daniel Agustin Godoy
Luca Masotti
Mario Di Napoli
Maurizio Paciaroni
Walter Ageno
P2860
P304
P356
10.1177/1076029612441055
P577
2012-05-19T00:00:00Z